|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-9-25
|
|
pubmed:abstractText |
We evaluated the therapeutic potential of intravenously injected basic fibroblast growth factor against the lethal syndromes associated with irradiation of intrathoracic organs and assessed whether such protection might be associated with inhibition of programmed cell death (apoptosis) in the exposed tissues.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1081-4442
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
62-72
|
|
pubmed:dateRevised |
2006-10-23
|
|
pubmed:meshHeading |
pubmed-meshheading:9166456-Animals,
pubmed-meshheading:9166456-Apoptosis,
pubmed-meshheading:9166456-Cell Survival,
pubmed-meshheading:9166456-Dose-Response Relationship, Radiation,
pubmed-meshheading:9166456-Fibroblast Growth Factor 2,
pubmed-meshheading:9166456-Humans,
pubmed-meshheading:9166456-Injections, Intravenous,
pubmed-meshheading:9166456-Lung,
pubmed-meshheading:9166456-Male,
pubmed-meshheading:9166456-Mediastinum,
pubmed-meshheading:9166456-Mice,
pubmed-meshheading:9166456-Mice, Inbred C3H,
pubmed-meshheading:9166456-Radiation Pneumonitis,
pubmed-meshheading:9166456-Radiation-Protective Agents,
pubmed-meshheading:9166456-Time Factors,
pubmed-meshheading:9166456-Whole-Body Irradiation
|
|
pubmed:articleTitle |
Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article
|
